The Akt/mTOR cascade mediates high glucose-induced reductions in BDNF via DNMT1 in Schwann cells in diabetic peripheral neuropathy

2019/07/16 by Cuihong Zhang, Cui-Hong Zhang, Xin Lv +7 · 7 citations
Neuroscience · Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Nerve injury and regeneration #Signaling Pathways in Disease #Toxin Mechanisms and Immunotoxins

paper · doi:10.1016/j.yexcr.2019.111502

Cited by

• DNA Methylome and Transcriptome Alterations in High Glucose-Induced Diabetic Nephropathy Cellular Model and Identification of Novel Targets for Treatment by Tanshinone IIA. [europepmc]
• TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression. [europepmc]
• Sildenafil Enhances the Therapeutic Effect of Islet Transplantation for Diabetic Peripheral Neuropathy via mTOR/S6K1 Pathway. [europepmc]
• Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. [europepmc]
• Metabolic memory: mechanisms and diseases. [europepmc]
• Adenosine Monophosphate-Activated Protein Kinase Activation and Mammalian Target of Rapamycin Complex 1 Inhibition: A Mechanistic Rationale for Anti-Aging Therapy in Type 2 Diabetes. [europepmc]
• Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions. [europepmc]